ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” second ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...

Health Insurance Giant’s Changing Fortunes UnitedHealth Group (NYSE:UNH) is the largest U.S. health insurer by market cap and ...

Want to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce in one fell swoop? You could ...

Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The ...

Andrew Witty has resigned as chief executive of US health conglomerate UnitedHealth Group, as the company pulled its financial forecasts for 2025, adding to a sense of crisis after a turbulent ...

The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.

The pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year amid what Optum Rx says is a push to improve patient access to critical medications.